HEllenic Multicenter ReAl-life CLInical Study for Bulevirtide Therapy in Chronic Hepatitis D: HERACLIS-BLV

Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment

NCT06504485 ·Status: RECRUITING

A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function

NCT05760300 ·Status: COMPLETED ·Phase: PHASE1

Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function

NCT05765344 ·Status: COMPLETED ·Phase: PHASE1

Expanded Access for Bulevirtide

NCT06780579 ·Status: AVAILABLE

Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)

NCT03852433 ·Status: COMPLETED ·Phase: PHASE2

Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection

NCT06603311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD)

NCT03852719 ·Status: COMPLETED ·Phase: PHASE3

Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection

NCT00371150 ·Status: COMPLETED ·Phase: PHASE4

Assessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus Infection

NCT07116044 ·Status: COMPLETED

An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection

NCT01037062 ·Status: COMPLETED ·Phase: PHASE2

Entecavir for Chronic Hepatitis B

NCT01323452 ·Status: COMPLETED

Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers

NCT02612506 ·Status: COMPLETED ·Phase: PHASE1

The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib

NCT03528941 ·Status: COMPLETED

A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection

NCT05612581 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase II Dose Response Study in Japan in Chronic Hepatitis B

NCT01022801 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks

NCT00862706 ·Status: WITHDRAWN ·Phase: PHASE4

Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program

NCT00096811 ·Status: NO_LONGER_AVAILABLE

A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection

NCT07142811 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]

NCT06216470 ·Status: RECRUITING ·Phase: PHASE2

Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B

NCT01581554 ·Status: COMPLETED

A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B

NCT03625102 ·Status: COMPLETED ·Phase: PHASE2

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection

NCT01079806 ·Status: COMPLETED ·Phase: PHASE3

Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy

NCT01037166 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)

NCT05808335 ·Status: UNKNOWN ·Phase: PHASE2

Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria

NCT04264312 ·Status: COMPLETED